True Blue Financial, LLC has filed a Form 13F-HR with the U.S. Securities and Exchange Commission, disclosing its equity holdings as of September 30, 2026. The filing lists 58 separate positions held by the firm.
The portfolio is heavily weighted toward exchange-traded funds (ETFs), with a significant portion of the assets managed through funds from the Capital Group and SPDR Series Trust. The Capital Group funds include Core Equity, Dividend Value, Growth, International Focus, and New Geography share classes, alongside various fixed income ETFs such as Core Bond, Core Plus Income, and U.S. Multi-Sector funds.
Among the individual stock holdings disclosed in the filing are AbbVie Inc., Alphabet Inc. Class C, Eli Lilly & Co., Rocket Lab Corp., and Old Republic International Corp. The filing indicates that the firm holds 2,176 shares of AbbVie, 682 shares of Alphabet, and 230 shares of Eli Lilly.
The report was signed by Lucas M. Brown, the Chief Compliance Officer of True Blue Financial, LLC, on October 15, 2026.
